4D Molecular Therapeutics, Inc.·4

May 16, 8:52 PM ET

Moretti August J 4

4 · 4D Molecular Therapeutics, Inc. · Filed May 16, 2023

Insider Transaction Report

Form 4
Period: 2023-05-15
Moretti August J
See Remarks
Transactions
  • Exercise/Conversion

    Common Stock

    2023-05-15$9.41/sh+3,000$28,23011,045 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2023-05-153,000217,060 total
    Exercise: $9.41Exp: 2029-03-19Common Stock (3,000 underlying)
Footnotes (2)
  • [F1]Reflects 1,450 shares of the Issuer's common stock purchased under the Issuer's Employee Stock Purchase Plan in a transaction exempt from Rule 16b-3.
  • [F2]The option is fully vested and exercisable

Documents

1 file
  • 4
    form4.xmlPrimary